drugset / Trial / NCT00717275

Study of Temozolomide to Treat Newly Diagnosed Brain Metastases

NCT00717275 ↗

Phase 2 Terminated 3 enrolled University of Florida
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if administering temozolomide after completion of stereotactic radiosurgery helps control existing brain metastases and prevents the developement of new brain metastases.

Timeline

Start
2008-09
Primary completion
2011-01
Completion
2011-06

Outcome

Outcome not reported

Stopped (Enrollment): “Slow accrual.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule 75 mg/m2 Oral